These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2098098)
1. Defective response of natural killer activity to thyroxine in Graves' disease. Lee MS; Hong WS; Hong SW; Lee JO; Kang TW Korean J Intern Med; 1990 Jul; 5(2):93-6. PubMed ID: 2098098 [TBL] [Abstract][Full Text] [Related]
2. Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism. Stein-Streilein J; Zakarija M; Papic M; McKenzie JM J Immunol; 1987 Oct; 139(7):2502-7. PubMed ID: 3498760 [TBL] [Abstract][Full Text] [Related]
3. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease. Marazuela M; Vargas JA; Alvarez-Mon M; Albarrán F; Lucas T; Durántez A Eur J Endocrinol; 1995 Feb; 132(2):175-80. PubMed ID: 7858736 [TBL] [Abstract][Full Text] [Related]
4. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969 [TBL] [Abstract][Full Text] [Related]
6. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. Papic M; Stein-Streilein J; Zakarija M; McKenzie JM; Guffee J; Fletcher MA J Clin Invest; 1987 Feb; 79(2):404-8. PubMed ID: 3492513 [TBL] [Abstract][Full Text] [Related]
7. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Solerte SB; Precerutti S; Gazzaruso C; Locatelli E; Zamboni M; Schifino N; Bonacasa R; Rondanelli M; Taccani D; Ferrari E; Fioravanti M Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis. Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716 [TBL] [Abstract][Full Text] [Related]
9. Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Hidaka Y; Amino N; Iwatani Y; Kaneda T; Nasu M; Mitsuda N; Tanizawa O; Miyai K Autoimmunity; 1992; 11(4):239-46. PubMed ID: 1581468 [TBL] [Abstract][Full Text] [Related]
10. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731 [TBL] [Abstract][Full Text] [Related]
11. Depressed natural killer activity in Graves' disease and during antithyroid medication. Wang PW; Luo SF; Huang BY; Lin JD; Huang MJ Clin Endocrinol (Oxf); 1988 Feb; 28(2):205-14. PubMed ID: 3168307 [TBL] [Abstract][Full Text] [Related]
12. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139 [TBL] [Abstract][Full Text] [Related]
13. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. Larsen PR J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364 [TBL] [Abstract][Full Text] [Related]
14. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells. Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944 [TBL] [Abstract][Full Text] [Related]
15. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751 [TBL] [Abstract][Full Text] [Related]
16. Role of natural killer T cells in Graves' disease. Luo W; Guo H; Aosai F; Yano A Chin Med J (Engl); 2002 Aug; 115(8):1183-5. PubMed ID: 12215288 [TBL] [Abstract][Full Text] [Related]
17. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
18. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis. Yoshida K; Sakurada T; Kaise N; Kaise K; Kitaoka H; Fukazawa H; Yamamoto M; Saito S; Yoshinaga K J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591 [TBL] [Abstract][Full Text] [Related]
19. Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease. Amino N; Mori H; Iwatani Y; Asari S; Izumiguchi Y; Miyai K J Clin Endocrinol Metab; 1982 Mar; 54(3):587-91. PubMed ID: 7035486 [No Abstract] [Full Text] [Related]
20. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]